CD56 Expression Is an Important Prognostic Factor in Multiple Myeloma Even with Bortezomib Induction.
Saved in:
| Title: | CD56 Expression Is an Important Prognostic Factor in Multiple Myeloma Even with Bortezomib Induction. |
|---|---|
| Authors: | Skerget M, Skopec B, Zadnik V, Zontar D, Podgornik H, Rebersek K, Furlan T, Cernelc P |
| Source: | Acta haematologica [Acta Haematol] 2018; Vol. 139 (4), pp. 228-234. Date of Electronic Publication: 2018 Jun 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 0141053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9662 (Electronic) Linking ISSN: 00015792 NLM ISO Abbreviation: Acta Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
